5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 27.64▲ | 27.63▲ | 27.63▲ | 27.37▲ | 26.40▲ |
MA10 | 27.63▲ | 27.62▲ | 27.62▲ | 27.20▲ | 25.72▲ |
MA20 | 27.62▲ | 27.51▲ | 27.45▲ | 26.51▲ | 25.06▲ |
MA50 | 27.41▲ | 27.29▲ | 27.21▲ | 25.65▲ | 25.66▲ |
MA100 | 27.22▲ | 26.93▲ | 26.57▲ | 25.11▲ | 26.35▲ |
MA200 | 26.64▲ | 26.14▲ | 25.82▲ | 25.69▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.010▼ | -0.002▼ | 0.001▲ | 0.074▲ | 0.352▲ |
RSI | 69.330▲ | 71.173▲ | 72.033▲ | 76.890▲ | 64.396▲ |
STOCH | 62.967 | 71.069 | 85.285▲ | 93.224▲ | 83.472▲ |
WILL %R | -14.286▲ | -6.061▲ | -2.410▲ | -0.905▲ | -0.464▲ |
CCI | 93.114 | 89.128 | 67.927 | 124.657▲ | 199.150▲ |
Friday, April 26, 2024 01:54 PM
Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LRBUSINESS HIGHLIGHTS 2023Despite the challenging market environment, EPH European Property Holdings PLC (“EPH” or the “Company”) maintained ...
|
Friday, April 26, 2024 03:51 AM
The benchmark indices ended lower, snapping a six-session rally, but recouped weekly losses.
|
Friday, April 26, 2024 12:19 AM
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/04/24 | 27.65 | 27.66 | 27.59 | 27.65 | 70,277 |
25/04/24 | 27.51 | 27.67 | 27.35 | 27.58 | 35,592 |
24/04/24 | 27.15 | 27.2844 | 27.14 | 27.14 | 24,116 |
23/04/24 | 27.17 | 27.26 | 27.16 | 27.23 | 50,356 |
22/04/24 | 27.11 | 27.28 | 27.11 | 27.26 | 53,876 |
19/04/24 | 27.18 | 27.2613 | 27.1363 | 27.17 | 28,970 |
18/04/24 | 26.92 | 27.16 | 26.92 | 27.06 | 54,981 |
17/04/24 | 26.90 | 27.0984 | 26.83 | 26.95 | 94,933 |
16/04/24 | 26.83 | 27.04 | 26.80 | 27.03 | 209,008 |
15/04/24 | 26.75 | 26.93 | 26.7282 | 26.93 | 126,146 |
|
|
||||
|
|
||||
|
|